Identifying quality leads - an important factor in reducing attrition of clinical candidates
Chackalamannil, S.; Desai, M.C.
Current Opinion in Drug Discovery and Development 10(4): 381-382
2007
ISSN/ISBN: 1367-6733 PMID: 17659478 Document Number: 612151
Document emailed within 1 workday
Related Documents
Brozmanová, J.; Dudás, A.; Henriques, J.A. 2001: Repair of oxidative DNA damage--an important factor reducing cancer risk. Minireview Neoplasma 48(2): 85-93Montgomery, J.A.; Palmer, P.E. 1976: Reducing attrition in an AD program Nursing Outlook 24(1): 49-51
Rogers, B.L. 2004: Bacterial targets to antimicrobial leads and development candidates Current Opinion in Drug Discovery and Development 7(2): 211-222
Gardette, V.; Coley, N.; Toulza, O.; Andrieu, S. 2007: Attrition in geriatric research: how important is it and how should it be dealt with? Journal of Nutrition Health and Aging 11(3): 265-271
Babinets, L.S.; Dronyak, Y.V.; Меlnyk, N.A. 2018: Concomitant ascariasis as a factor in reducing the quality of life of patients with chronic pancreatitis Wiadomosci Lekarskie 71(7): 1250-1253
Guo, Z.-r. 2008: Strategy of molecular drug design: hits, leads and drug candidates Yao Xue Xue Bao 43(9): 898-904
Ritter, A.J.; Wodak, A.D.; Crofts, J.N. 2004: Reducing drug-related harm: Australia leads the way Medical Journal of Australia 181(5): 242-243
Caldicott, D.G.E.; Duff, C. 2005: Reducing drug-related harm: Australia leads the way Medical Journal of Australia 182(3): 140; Author Reply 141
Phani, M.N.; Satyamoorthy, K. 2014: ABCB1 variant provides important leads for pharmacogenetics of epilepsy Journal of Postgraduate Medicine 60(3): 239-240
Watson, M.E.; Mayhew, P.A. 1994: Identifying fall risk factors in preparation for reducing the use of restraints Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 3(1): 25-28; 30, 35
Adams, E.D.; Cooper, B.H. 1974: Evaluation of a modified Wickerham medium for identifying medically important yeasts American Journal of Medical Technology 40(9): 377-388
Valentine, N.; Darby, C.; Bonsel, G.J. 2008: Which aspects of non-clinical quality of care are most important? Results from WHO's general population surveys of "health systems responsiveness" in 41 countries Social Science and Medicine 66(9): 1939-1950
Sato, H.; Hoshi, M.; Sugiyama, K.; Urushiyama, M.; Ishizuka, K. 1994: Optimal induction and maintenance of the hypertensive state an important factor in clinical advantages of angiotensin Ii induced hypertension chemotherapy (IHC) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(Suppl 4): 459-461
Mauri, M.; Rucci, P.; Calderone, A.; Santini, F.; Oppo, A.; Romano, A.; Rinaldi, S.; Armani, A.; Polini, M.; Pinchera, A.; Cassano, G.B. 2008: Axis I and II disorders and quality of life in bariatric surgery candidates Journal of Clinical Psychiatry 69(2): 295-301
Ashcroft, B.; Eistein, M.; Boreham, N. 2000: Reducing error, improving safety. Systems approach to intrapartum risk management is important Bmj 321(7259): 508
Del Corso, C.; Caravello, G.; Betti, M.G.; Ferretti, S.; Lunardi, W.; Tavolaro, A.; Capitanini, A.; Petrone, I.; Rossi, A.; Cerri, A.; Galati, V.; Marini, M.; Sardi, T.; Valenti, I. 2008: Dialysis and quality of life: identifying and managing critical aspects Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 25(2): 215-222
Kyo, R.; Nakahata, N.; Sakakibara, I.; Kubo, M.; Ohizumi, Y. 1998: Baicalin and baicalein, constituents of an important medicinal plant, inhibit intracellular Ca2+ elevation by reducing phospholipase C activity in C6 rat glioma cells Journal of Pharmacy and Pharmacology 50(10): 1179-1182
Bergström, R. 2006: Discount for only one drug of the same group leads to impaired health care quality Lakartidningen 103(6): 387-388; Discussion 388
Takahashi, T.; Wada, T.; Mori, M.; Kokai, Y.; Ishii, S. 1996: Overexpression of the granulocyte colony-stimulating factor gene leads to osteoporosis in mice Laboratory Investigation; a Journal of Technical Methods and Pathology 74(4): 827-834
1986: Leads from the MMWR. Behavioral risk-factor surveillance in selected states--1985 JAMA 256(6): 697-698